My Quote Request
6505-01-357-5379
20 Products
NDC00074-6215-53
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS
NSN, MFG P/N
6505013575379
NSN
6505-01-357-5379
NDC00074-6215-53
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS
NSN, MFG P/N
6505013575379
NSN
6505-01-357-5379
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIVALPROEX SODIUM TABLETS 500S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500 MG VALPROIC ACID
THERAPEUTIC EQUIVALENT: DEPAKOTE BY ABBOTT
Related Searches:
NDC00093-0314-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
NDC00093-0314-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS KETOROLAC TROMETHAMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: TORADOL BY SYNTEX LABORATORIES,INC.
Related Searches:
NDC00378-1134-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
NDC00378-1134-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS KETOROLAC TROMETHAMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: TORADOL BY SYNTEX LABORATORIES,INC.
Related Searches:
NDC50111-0608-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
NDC50111-0608-01
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS KETOROLAC TROMETHAMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: TORADOL BY SYNTEX LABORATORIES,INC.
Related Searches:
NDC58177-0301-04
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
NDC58177-0301-04
KETOROLAC TROMETHAMINE TABLETS,USP
NSN, MFG P/N
6505013575366
NSN
6505-01-357-5366
MFG
ETHEX CORP SUB OF K-V PHARMACEUTICAL CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS KETOROLAC TROMETHAMINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOROLAC TROMETHAMINE TABLETS USP 10MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: TORADOL BY SYNTEX LABORATORIES,INC.
Related Searches:
NDC00026-0603-20
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575368
NSN
6505-01-357-5368
NDC00026-0603-20
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575368
NSN
6505-01-357-5368
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTITHROMBIN III HUMAN FOR INJECTION 500 INTERNATIONAL UNITS
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: TO THROMBATE III BY MILES PHARMACEUTICALS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: BT W/10 ML STERILE WATER FOR INJECTION,USP; STERILE DOUBLE-ENDED TRANSFER NEEDLE AND A STERILE FILTER NEEDLE
Related Searches:
THROMBATE III
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575368
NSN
6505-01-357-5368
THROMBATE III
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575368
NSN
6505-01-357-5368
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTITHROMBIN III HUMAN FOR INJECTION 500 INTERNATIONAL UNITS
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: TO THROMBATE III BY MILES PHARMACEUTICALS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: BT W/10 ML STERILE WATER FOR INJECTION,USP; STERILE DOUBLE-ENDED TRANSFER NEEDLE AND A STERILE FILTER NEEDLE
Related Searches:
NDC00026-0603-30
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575369
NSN
6505-01-357-5369
NDC00026-0603-30
ANTITHROMBIN III,HUMAN,FOR INJECTION
NSN, MFG P/N
6505013575369
NSN
6505-01-357-5369
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTITHROMBIN III HUMAN FOR INJECTION 1000 INTERNATIONAL UNITS
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: TO THROMBATE III BY MILES PHARMACEUTICALS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: BT W/20 ML STERILE WATER FOR INJECTION,USP; STERILE DOUBLE-ENDED TRANSFER NEEDLE AND A STERILE FILTER NEEDLE
Related Searches:
00378910293
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
00378910293
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
MFG
MYLAN PHARMACEUTICALS INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 20MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 20 MG NIROGLYCERINE ACTIVE INGREDENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.100 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00085-3305-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
NDC00085-3305-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 20MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 20 MG NIROGLYCERINE ACTIVE INGREDENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.100 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00089-1301-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
NDC00089-1301-30
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
MFG
3M COMPANY HEALTH CARE/MFG
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 20MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 20 MG NIROGLYCERINE ACTIVE INGREDENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.100 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575370
NSN
6505-01-357-5370
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 20MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 20 MG NIROGLYCERINE ACTIVE INGREDENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.100 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00085-3330-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
NDC00085-3330-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 120MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 120 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.600 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00378-9116-93
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
NDC00378-9116-93
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
MFG
MYLAN PHARMACEUTICALS INC
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 120MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 120 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.600 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575371
NSN
6505-01-357-5371
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 120MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 120 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.600 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00085-3320-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575372
NSN
6505-01-357-5372
NDC00085-3320-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575372
NSN
6505-01-357-5372
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 80MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 80 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.400 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575372
NSN
6505-01-357-5372
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575372
NSN
6505-01-357-5372
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 80MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 80 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.400 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NDC00085-3315-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575373
NSN
6505-01-357-5373
NDC00085-3315-35
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575373
NSN
6505-01-357-5373
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 60MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 60 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.300 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575373
NSN
6505-01-357-5373
NITRO-DUR
NITROGLYCERIN TRANSDERMAL SYSTEM
NSN, MFG P/N
6505013575373
NSN
6505-01-357-5373
MFG
SCHERING-PLOUGH CORPORATION
Description
FEATURES PROVIDED: BANDAGE, ADHESIVE, NONSENSITIZED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 60MG BANDAGE 30S
OVERALL STRENGTH IN SYSTEM: 60 MG NITROGLYCERINE ACTIVE INGREDIENT
SPECIAL FEATURES: INSTITUTIONAL PACK
THERAPEUTIC EQUIVALENT: NITRO-DUR BY SCHERING
USUAL DOSE: 0.300 MILLIGRAMS NITROGLYCERIN RELEASED PER HOUR
Related Searches:
DEPAKOTE
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS
NSN, MFG P/N
6505013575379
NSN
6505-01-357-5379
DEPAKOTE
DIVALPROEX SODIUM DELAYED-RELEASE TABLETS
NSN, MFG P/N
6505013575379
NSN
6505-01-357-5379
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIVALPROEX SODIUM TABLETS 500S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EQUIVALENT TO 500 MG VALPROIC ACID
THERAPEUTIC EQUIVALENT: DEPAKOTE BY ABBOTT